Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction

Table 3 Correlation between biventricular indexed EAT volume and clinical, imaging, biological continuous variables in controls, pre-HF patients, and HFpEF patients in the Belgian cohort, matched for sex and age

Variables	R Pearson	P-value
Age	− 0.05	0.54
BMI	0.30	< 0.001
NT-proBNP	0.37	< 0.001
eGFR by CK-EPI	− 0.21	0.013
Triglycerides	− 0.05	0.60
Blood glucose	0.22	0.011
hsTnT	0.41	< 0.001
FGF-23	0.22	0.009
Soluble ST2	0.30	< 0.001
Neutrophils	0.26	0.002
CRP	0.22	0.016
H₂FPEF score	0.41	0.003
LA volume, indexed, by echo	0.33	< 0.001
RA volume, indexed, by echo	0.19	0.025
EF Simpson by echo	− 0.14	0.08
E/e’	0.33	< 0.001
TAPSE	− 0.33	< 0.001
LV global longitudinal strain	0.35	< 0.001
RV global longitudinal strain	0.19	0.09
LV mass, indexed, by cMR	0.20	0.015
ECV	0.14	0.095
LGE	0.24	0.004

BMI Body mass index, CK‐EPI Chronic Kidney Disease Epidemiology Collaboration, CMR Cardiovascular magnetic resonance, CRP C-reactive protein, ECV Extracellular volume, eGFR Estimated glomerular filtration rate, FGF-23 Fibroblast growth factor-23, HF Heart failure, hsTnT High-sensitive troponin T, LA Left atrium, LGE Late gadolinium enhancement, LV Left ventricular, NT-proBNP N-terminal pro B-type natriuretic peptide, TAPSE Tricuspid annular plane systolic excursion, ST2 Suppression of tumorigenicity-2

ISSN: 1475-2840